EcoDrugPlus

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSBBBG00000002924
Gene Symbol: IMPDH1
3 Cross references
332 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSBBBG00000002761
Gene Symbol: IMPDH2
3 Cross references
202 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSBBBG00000000559
Gene Symbol: INPP5D
3 Cross references
214 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSBBBG00000006525
Gene Symbol: IGF1R
3 Cross references
276 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSBBBG00000018333
Gene Symbol: INSR
3 Cross references
290 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSBBBG00000004877
Gene Symbol: ITGA2B
3 Cross references
191 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSBBBG00000005904
Gene Symbol: ITGA4
3 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSBBBG00000004578
Gene Symbol: ITGA5
3 Cross references
267 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSBBBG00000019035
Gene Symbol: ITGAV
3 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSBBBG00000001028
Gene Symbol: ITGB1
3 Cross references
301 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSBBBG00000008739
Gene Symbol: ITGB3
3 Cross references
268 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSBBBG00000011341
Gene Symbol: ITGB5
3 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).